Schedule 13G ownership disclosure
PMV PHARMACEUTICALS INC
Common stock, par $0.00001 per share (the "Shares") · CUSIP: 69353Y103
Event date: 2025-03-31
Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.
- Filing-level shares
- Unavailable
- Percent of class
- Unavailable
- PFM Health Sciences, LP
Shares: 3,301,942.00 · Class: 6.4%
- PFM Health Sciences GP, LLC
Shares: 3,301,942.00 · Class: 6.4%
- Partner Asset Management, LLC
Shares: 3,301,942.00 · Class: 6.4%
- Brian D. Grossman
Shares: 3,301,942.00 · Class: 6.4%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001104659-25-049430
- Form type
- SCHEDULE 13G/A
- Filer
- PFM Health Sciences, LP
- CIK
- CIK 1442756
- Filed
- May 15, 2025
- Reporting period
- Mar 31, 2025
- Description
- Schedule 13G beneficial ownership